NewLink Genetics

These 3 Biotechs Have Been Crushed
These 3 Biotechs Have Been Crushed
Motley Fool
Xbiotech
Merrimack Pharmaceuticals
NewLink Genetics
Flag link:
Roche ditches work on NewLink’s IDO cancer candidate
Roche ditches work on NewLink’s IDO cancer candidate
Fierce Biotech
Roche
NewLink Genetics
indoximod
metastatic breast cancer
Flag link:
Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for
Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for
Endpoints
ASCO
IDO inhibitors
CAR-T
PDL-1 inhibitors
Merck
Incyte
NewLink Genetics
Novartis
Juno Therapeutics
Bristol-Myers Squibb
Flag link:
7 Areas to watch from the ASCO abstracts
7 Areas to watch from the ASCO abstracts
BioPharma Dive
ASCO 2017
oncology
Incyte
Merck
Eli Lilly
CAR-T
NewLink Genetics
Amgen
Roche
Kite Pharma
Juno Therapeutics
Flag link:
Why NewLink Genetics Shares Fell 10.3% Today
Why NewLink Genetics Shares Fell 10.3% Today
Motley Fool
NewLink Genetics
indoximod
melanoma
Flag link:
NewLink axes 100 staffers, shrinks pipeline in wake of a PhIII debacle
NewLink axes 100 staffers, shrinks pipeline in wake of a PhIII debacle
Endpoints
NewLink Genetics
layoffs
clinical trials
algenpantucel-L
Flag link:
3 Shocking Biotech Flops of 2016 So Far
3 Shocking Biotech Flops of 2016 So Far
Motley Fool
biotech
Rintega
Celldex Therapeutics
glioblastoma
Clovis Oncology
rociletinib
lung cancer
NewLink Genetics
algenpantucel-L
pancreatic cancer
Flag link:
7 Companies in the Fight to Defeat the Zika Virus
7 Companies in the Fight to Defeat the Zika Virus
24/7 Wall St
Zika virus
R&D
Gilead Sciences
Inovio
Intrexon
NewLink Genetics
Quest Diagnostics
Sanofi
Flag link:
NewLink Genetics writes off pancreatic cancer immunotherapy after phase 3 failure
NewLink Genetics writes off pancreatic cancer immunotherapy after phase 3 failure
BioPharma Dive
NewLink Genetics
pancreatic cancer
algenpantucel-L
Flag link:
The Race to Cure the Zika Virus is On, and This Company May Have the Best Solution
The Race to Cure the Zika Virus is On, and This Company May Have the Best Solution
Motley Fool
Zika virus
Invovio
GSK
NewLink Genetics
Sanofi
Merck
Cerus
Intrexon
Flag link:
Can NewLink Genetics Win the Zika Vaccine Race?
Can NewLink Genetics Win the Zika Vaccine Race?
Motley Fool
NewLink Genetics
vaccines
ebola virus
Zika virus
Flag link:
NewLink Genetics Vaccine May Improve How We Treat Pancreatic Cancer
NewLink Genetics Vaccine May Improve How We Treat Pancreatic Cancer
Motley Fool
vaccines
pancreatic cancer
NewLink Genetics
algenpantucel-L
clinical trials
Flag link:
4 Stocks Moving On Breast-Cancer News
4 Stocks Moving On Breast-Cancer News
Investors.com
breast cancer
neratinib
Puma Biotechnology
indoximod
NewLink Genetics
Seattle Genetics
SGN-LIV1A
Myriad Genetics
myChoice HRD
Flag link:
From Cancer To Ebola, NewLink Genetics Seeks Vaccines
From Cancer To Ebola, NewLink Genetics Seeks Vaccines
Investors.com
vaccines
NewLink Genetics
ebola virus
cancer
ovarian cancer
Flag link:
Did Merck and NewLink Genetics Just Cure Ebola?
Did Merck and NewLink Genetics Just Cure Ebola?
Motley Fool
Merck
NewLink Genetics
ebola virus
rVSV-ZEBOV
vaccines
Flag link:
NewLink Genetics shares fall after saying it will continue pancreatic cancer treatment study
NewLink Genetics shares fall after saying it will continue pancreatic cancer treatment study
Yahoo/AP
NewLink Genetics
pancreatic cancer
algenpantucel-L
Flag link:
Two Experimental Ebola Vaccines Appear to Be Safe in Trial
Two Experimental Ebola Vaccines Appear to Be Safe in Trial
WSJ Online
vaccines
ebola virus
GSK
Merck
NewLink Genetics
Flag link:
Expect More M&A Activity In Red-Hot Biotech Group
Expect More M&A Activity In Red-Hot Biotech Group
Investors.com
biotech
M&A
AbbVie
Pharmacyclics
Isis Pharmaceuticals
JNJ
Merck
NewLink Genetics
Roche
Flag link:
Merck-NewLink Ebola vaccine Phase III trial to start March 7
Merck-NewLink Ebola vaccine Phase III trial to start March 7
Yahoo/Reuters
Merck
NewLink Genetics
vaccines
ebola virus
Flag link:
Ebola Vaccines May Get Faster Approval Amid Outbreak’s Wane
Ebola Vaccines May Get Faster Approval Amid Outbreak’s Wane
Bloomberg
vaccines
approvals
ebola virus
GSK
Merck
NewLink Genetics
Flag link: